BDBM50325835 2-(6-(6-aminohexyloxy)-4-oxo-2-phenylquinazolin-3(4H)-yl)-N-(cyclopropylmethyl)acetamide::CHEMBL1223630
SMILES: NCCCCCCOc1ccc2nc(-c3ccccc3)n(CC(=O)NCC3CC3)c(=O)c2c1
InChI Key: InChIKey=IALLWEYPZHBRLF-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM50325835![]() (2-(6-(6-aminohexyloxy)-4-oxo-2-phenylquinazolin-3(...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Displacement of [3H]AVP from human vasopresin3 receptor expressed in CHO cells | Bioorg Med Chem Lett 20: 5394-7 (2010) Article DOI: 10.1016/j.bmcl.2010.07.118 BindingDB Entry DOI: 10.7270/Q2222TZ5 | |||||||||||
More data for this Ligand-Target Pair |